DEFI Venture is a private equity general partner firm headquartered in Lausanne, Switzerland.
Aleva Neurotherapeutics, a Swiss developer of next-generation implants for deep brain stimulation, has collected $18m in a Series C round.
NeoMed participated in a 1.3m Swiss francs funding round for Diagnoplex SA, a developer of molecular diagnostics for colon cancer.
Read more news concerning DEFI Venture
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?